Prostate cancer blood test detects twice as many cases
A new multicomponent blood test is demonstrating higher detection rates for clinically significant prostate cancer compared to traditional PSA testing.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
A new multicomponent blood test, specifically Stockholm3, outperformed PSA in detecting high-risk and clinically significant prostate cancers. Reports indicated the test could detect twice as many cases and improve screening when used with MRI.
Epilogue added 10d ago, after coverage quieted.
The brief
The Stockholm3 blood test is being reported as more effective than the standard PSA test for identifying high-risk and clinically significant prostate cancer. According to The Telegraph, this test detects twice as many cases.
Coverage from MedPage Today, Medical Xpress, and 2 Minute Medicine emphasizes that the multicomponent test outperforms PSA in identifying significant cancers. AuntMinnie notes that this blood-based testing could further improve screening when used in conjunction with MRI.
Future focus remains on the integration of these blood tests with imaging technologies to enhance prostate cancer screening outcomes.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 23d ago.
Quick answers
What is the name of the new blood test?
The test is identified in coverage as Stockholm3.
How does it compare to the traditional PSA test?
According to The Telegraph, it detects twice as many cases, while other reports state it outperforms PSA for clinically significant and high-risk cancers.
Can this test be used with other diagnostic tools?
Yes, coverage from AuntMinnie indicates that blood-based testing could improve screening when used with MRI.
Coverage (5)
- Multicomponent Test Tops PSA for Clinically Significant Prostate Cancers MedPage Today · 25d ago
- Blood-based testing could improve prostate cancer screening with MRI AuntMinnie · 25d ago
- Stockholm3 outperforms PSA for detecting significant prostate cancer 2 Minute Medicine · 25d ago
- New blood test detects more high-risk prostate cancer cases Medical Xpress · 25d ago
- Prostate cancer blood test detects twice as many cases The Telegraph · 25d ago
Topics
Related trends
Prostate cancer treatment with fewer side effects 'as effective as radiotherapy and surgery'
A study from Imperial College Healthcare NHS Trust indicates focal therapy for prostate cancer matches surgery and radiotherapy in efficacy.
Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance
Abbott Laboratories shares hit a three-month high and recorded their best day in 24 years following strong Q2 2026 results.
Alzheimer's blood test may predict who's likely to develop symptoms in 5 to 10 years
13 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
These Look Like Ordinary X-Rays. They’re Not
Astronauts have successfully captured the first human X-rays in space, marking a significant milestone for extraterrestrial medical diagnostics.
Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients
New data suggests a second PSMA PET scan can alter treatment plans for nearly half of patients with prostate cancer.
'Endometriosis tests would have given me years back'
New diagnostic tools, including blood and saliva tests, aim to reduce the years-long wait for endometriosis diagnosis.